# Safety and Efficacy Study of EGP-437 (Dexamethasone Phosphate Formulated for Ocular Iontophoresis) to Treat Dry Eye

> **NCT01129856** · PHASE3 · COMPLETED · sponsor: **Eyegate Pharmaceuticals, Inc.** · enrollment: 198 (actual)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** Dexamethasone phosphate ophthalmic solution
- **DRUG:** Sodium citrate buffer solution

## Key facts

- **NCT ID:** NCT01129856
- **Lead sponsor:** Eyegate Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-01
- **Final completion:** 2011-04
- **Target enrollment:** 198 (ACTUAL)
- **Last updated:** 2011-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01129856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01129856, "Safety and Efficacy Study of EGP-437 (Dexamethasone Phosphate Formulated for Ocular Iontophoresis) to Treat Dry Eye". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01129856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*